Javascript must be enabled to continue!
EFFECT OF PLATELETPHERESIS ON PLATELET COUNT IN DONORS
View through CrossRef
Background: Platelet transfusion plays a vital role in the management of patients with hematological malignancies, oncological treatments, major surgeries, and organ transplants. Plateletpheresis has become increasingly popular for obtaining single donor platelets (SDP) due to its ability to yield high-quality products. However, the procedure may temporarily alter the donor’s hematologic profile, especially platelet count. Monitoring these changes is essential to ensuring donor safety and maintaining sustainable donation practices.
Objective: To determine the mean change in platelet count in healthy donors one hour after undergoing plateletpheresis.
Methods: This quasi-experimental study was conducted in the Blood Bank and Hematology Laboratory at Lahore General Hospital. A total of 60 healthy donors aged 19–45 years, meeting standard eligibility criteria, were included. Venous blood samples (3 mL) were collected under aseptic conditions in K₂EDTA vacutainers before and one hour after the plateletpheresis procedure. Platelet counts were measured using the Nihon Kohden MEK 9100 hematology analyzer. Plateletpheresis was performed using the Fresenius Kabi COM.TEC C5L HemoCare system. Data were analyzed using SPSS version 26.0. A paired sample t-test was applied to evaluate the difference in platelet counts pre- and post-donation, considering p < 0.05 as statistically significant.
Results: Among the 60 donors, 59 (98.3%) were male and 1 (1.7%) was female. The mean age was 35.2 ± 10.8 years, and 8 donors (13.3%) were repeat participants. The mean platelet count prior to donation was 289.5 ± 51.2 × 10⁹/L, which decreased significantly to 218.0 ± 48.6 × 10⁹/L one-hour post-procedure (p < 0.001).
Conclusion: Plateletpheresis causes a statistically significant reduction in donor platelet counts shortly after the procedure, emphasizing the need for post-donation monitoring and guidelines to ensure donor safety.
Health and Research Insights
Title: EFFECT OF PLATELETPHERESIS ON PLATELET COUNT IN DONORS
Description:
Background: Platelet transfusion plays a vital role in the management of patients with hematological malignancies, oncological treatments, major surgeries, and organ transplants.
Plateletpheresis has become increasingly popular for obtaining single donor platelets (SDP) due to its ability to yield high-quality products.
However, the procedure may temporarily alter the donor’s hematologic profile, especially platelet count.
Monitoring these changes is essential to ensuring donor safety and maintaining sustainable donation practices.
Objective: To determine the mean change in platelet count in healthy donors one hour after undergoing plateletpheresis.
Methods: This quasi-experimental study was conducted in the Blood Bank and Hematology Laboratory at Lahore General Hospital.
A total of 60 healthy donors aged 19–45 years, meeting standard eligibility criteria, were included.
Venous blood samples (3 mL) were collected under aseptic conditions in K₂EDTA vacutainers before and one hour after the plateletpheresis procedure.
Platelet counts were measured using the Nihon Kohden MEK 9100 hematology analyzer.
Plateletpheresis was performed using the Fresenius Kabi COM.
TEC C5L HemoCare system.
Data were analyzed using SPSS version 26.
A paired sample t-test was applied to evaluate the difference in platelet counts pre- and post-donation, considering p < 0.
05 as statistically significant.
Results: Among the 60 donors, 59 (98.
3%) were male and 1 (1.
7%) was female.
The mean age was 35.
2 ± 10.
8 years, and 8 donors (13.
3%) were repeat participants.
The mean platelet count prior to donation was 289.
5 ± 51.
2 × 10⁹/L, which decreased significantly to 218.
0 ± 48.
6 × 10⁹/L one-hour post-procedure (p < 0.
001).
Conclusion: Plateletpheresis causes a statistically significant reduction in donor platelet counts shortly after the procedure, emphasizing the need for post-donation monitoring and guidelines to ensure donor safety.
Related Results
PATHOPHYSIOLOGY OF THROMBOCYTOPENIA AND RESULTANT CLINICAL INDICATIONS FOR PLATELET TRANSFUSION
PATHOPHYSIOLOGY OF THROMBOCYTOPENIA AND RESULTANT CLINICAL INDICATIONS FOR PLATELET TRANSFUSION
Careful evaluation of platelet survival data in normal individuals and patients with thrombocytopeniasecondary to marrow aplasia has demonstrated that platelets are lost from circu...
Haematological Changes in Donors Post Apheresis
Haematological Changes in Donors Post Apheresis
Introduction: The productivity, quality of platelet apheresis collection has improved because of the considerable advancement in the automated cell separators. Automated cell separ...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract
Introduction
Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
REASONS OF DONOR DEFERRAL FOR A SINGLE DONOR PLATELETPHERESIS IN A PUBLIC SECTOR BLOOD TRANSFUSION CENTRE OF LAHORE: A CROSS-SECTIONAL STUDY
REASONS OF DONOR DEFERRAL FOR A SINGLE DONOR PLATELETPHERESIS IN A PUBLIC SECTOR BLOOD TRANSFUSION CENTRE OF LAHORE: A CROSS-SECTIONAL STUDY
Background and Objective: Plateletpheresis is a process by which platelets are extracted from the donor. Donor selection is critical since donors are the sole supply of blood avail...
A Multicenter Study of donor deferral Rates and Reasons in Plateletpheresis
A Multicenter Study of donor deferral Rates and Reasons in Plateletpheresis
Background: Demand for platelets has increased in recent years due to rising oncology cases, dengue fever, and other conditions associated with low platelet counts. The Transfusion...
Platelet and Red Blood Cell Indices in Harris Platelet Syndrome.
Platelet and Red Blood Cell Indices in Harris Platelet Syndrome.
Abstract
Inherited giant platelet disorders are a group of rare disorders characterized by thrombocytopenia, giant platelets and variable bleeding symptoms. Naina et...
Establishing an HLA-Typed Plateletpheresis Donor Registry at the Iranian Blood Transfusion Organization
Establishing an HLA-Typed Plateletpheresis Donor Registry at the Iranian Blood Transfusion Organization
Administering human leukocyte antigen (HLA)-compatible platelets is a tactic for treating patients with poor responses to random platelet injections. HLA-matched platelet provision...
Abstract 1645: Innovative discovery of therapeutic plateletpheresis in patients with thrombocytosis using the Fresenius COM.TEC
Abstract 1645: Innovative discovery of therapeutic plateletpheresis in patients with thrombocytosis using the Fresenius COM.TEC
Abstract
Plateletpheresis is an important therapeutic method for treatment of patients with myeloproliferative neoplasms (MPN) presenting with thrombocytosis. This s...

